Medicxi Ventures Management (Jersey) LTD Rapt Therapeutics, Inc. Transaction History
Medicxi Ventures Management (Jersey) LTD
- $660 Million
- Q3 2025
A detailed history of Medicxi Ventures Management (Jersey) LTD transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Medicxi Ventures Management (Jersey) LTD holds 2,794,000 shares of RAPT stock, worth $80.6 Million. This represents 10.91% of its overall portfolio holdings.
Number of Shares
2,794,000Holding current value
$80.6 Million% of portfolio
10.91%Shares
2 transactions
Others Institutions Holding RAPT
# of Institutions
13Shares Held
8.03MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY2.44MShares$70.4 Million0.0% of portfolio
-
Ponoi Management, LLC San Francisco, CA1.6MShares$46.1 Million52.54% of portfolio
-
Kpcb Xv Associates, LLC649KShares$18.7 Million43.54% of portfolio
-
Column Group LLC San Francisco, CA166KShares$4.79 Million5.41% of portfolio
-
Ponoi Ii Management, LLC San Francisco, CA145KShares$4.19 Million9.14% of portfolio
About RAPT Therapeutics, Inc.
- Ticker RAPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,656,600
- Market Cap $856M
- Description
- RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...